Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Voglibose I.P. 0.2 Tablets
Therapeutic Category
Antidiabetic, Diabetic, Endocrinology
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹89/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Vogliviga 0.2 Tablet contains Voglibose 0.2mg, an oral alpha-glucosidase inhibitor used in the management of type 2 diabetes mellitus. It works by delaying the digestion and absorption of carbohydrates in the intestine, thereby preventing a sudden spike in postprandial (after meal) blood sugar levels. Vogliviga 0.2 Tablet is especially useful in patients whose blood glucose levels are not adequately controlled by diet, exercise, or other oral antidiabetics. It complements other antidiabetic therapies by targeting post-meal glucose control without causing hypoglycemia when used alone.
May cause flatulence, abdominal discomfort, bloating, or diarrhea. These side effects are generally mild and subside with continued use. Rarely, serious gastrointestinal disturbances may occur.
Used for the management of postprandial hyperglycemia in patients with type 2 diabetes mellitus, as part of an overall diabetes treatment plan including diet and exercise.
Not recommended for patients with inflammatory bowel disease, intestinal obstruction, or chronic digestive disorders. Regular monitoring of blood glucose is essential. Should be used under medical supervision, particularly in patients with renal or hepatic impairment.
Store in a cool, dry place below 25°C. Protect from direct sunlight and moisture. Keep out of the reach of children.
Composition : Atorvastatin Calcium I.P. 10mg Tablets
Composition : Atorvastatin Calcium I.P. 20mg Tablets
Composition : Atorvastatin Calcium I.P. 40mg Tablets
Composition : Atorvastatin Calcium I.P. 80mg Tablets
Composition : Atorvastatin Calcium I.P. 10mg + Clopidogrel I.P. 75mg Tablets
Composition : Atorvastatin Calcium I.P. 10mg + Fenofibrate I.P. 160mg Tablets
Composition : Dapagliflozin 10mg + Metformin Hydrochloride I.P. 500mg Tablets
Composition : Dapagliflozin 10mg + Metformin Hydrochloride I.P. 1000mg Tablets
Composition : Dapagliflozin Propanediol Monohydrate 10mg + Vildagliptin I.P. 100mg Tablets
Composition : Metformin 1000mg (S.R.) Tablets
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Vogliviga 0.2 Tablet has strong demand in the anti-diabetic segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on diabetology and chronic-care portfolios.
Medical distributors and agencies can benefit from consistent demand for management of type 2 diabetes mellitus and post-meal (postprandial) blood sugar control. Voglibose 0.2mg helps delay carbohydrate absorption in the intestine, reducing after-meal blood sugar spikes This supports better overall glycemic control and strengthens a reliable anti-diabetic portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Vogliviga 0.2 Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong diabetologist prescriptions, consistent chronic-care demand, large diabetic patient base, reliable supply chain support, and good margins in anti-diabetic medicines.
Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to discuss pricing, monopoly territory rights, and distribution opportunities.